Published in J Nucl Med on March 01, 1997
Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? For. Eur J Nucl Med Mol Imaging (2002) 1.39
Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma. World J Gastroenterol (2005) 0.82
Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer. Clin Cancer Res (2008) 0.81
Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers. BMC Cancer (2004) 0.80
Feasibility of 186Re-radioimmunotherapy for treatment in an adjuvant setting of colon cancer. J Cancer Res Clin Oncol (2003) 0.75
Recent advances of bispecific antibodies in solid tumors. J Hematol Oncol (2017) 0.75
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med (1978) 3.00
Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. J Nucl Med (1996) 2.83
Model-checking techniques based on cumulative residuals. Biometrics (2002) 2.58
A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience (2002) 2.58
Estimating a treatment effect under biased sampling. Proc Natl Acad Sci U S A (1988) 2.49
Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle. Eur J Neurosci (2001) 1.95
The long-term mental health consequences of child sexual abuse: an exploratory study of the impact of multiple traumas in a sample of women. J Trauma Stress (2001) 1.86
Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity. Neuroscience (2003) 1.83
Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res (1980) 1.82
Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience (2006) 1.72
Exercise reverses the harmful effects of consumption of a high-fat diet on synaptic and behavioral plasticity associated to the action of brain-derived neurotrophic factor. Neuroscience (2004) 1.69
Photoscan localization of GW-39 tumors in hamsters using radiolabeled anticarcinoembryonic antigen immunoglobulin G. Cancer Res (1974) 1.63
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J Clin Oncol (1991) 1.61
Rickettsial relative associated with papaya bunchy top disease. Curr Microbiol (1998) 1.61
Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens. Cancer (1978) 1.58
A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor. Neuroscience (2003) 1.56
Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study. Int J Radiat Oncol Biol Phys (1996) 1.55
Estimating the superiority of a drug to a placebo when all and only those patients at risk are treated with the drug. Proc Natl Acad Sci U S A (1989) 1.52
Intestinal perforation, exchange transfusion, and P.V.C. Lancet (1969) 1.51
Exercise impacts brain-derived neurotrophic factor plasticity by engaging mechanisms of epigenetic regulation. Eur J Neurosci (2010) 1.48
A new method for delivering radioactive cytotoxic agents in solid cancers. Int J Radiat Oncol Biol Phys (1994) 1.47
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members. J Nucl Med (2001) 1.47
Normal colonic epithelium adheres to carcinoembryonic antigen and type IV collagen. Gastroenterology (1994) 1.45
MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med (1999) 1.44
The need for better methods to determine release criteria for patients administered radioactive material. Health Phys (1998) 1.44
Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience (2008) 1.41
Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR. J Nucl Med (2000) 1.41
Does filter media type really affect BRS? Indoor Air (2009) 1.39
Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy. Clin Lymphoma (2000) 1.39
Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections. J Natl Cancer Inst (1976) 1.38
A multicenter study of primary graft failure after infant heart transplantation: impact of extracorporeal membrane oxygenation on outcomes. Pediatr Transplant (2013) 1.38
Dose escalation of radioantibody in a mouse model with the use of recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor intervention to reduce myelosuppression. J Natl Cancer Inst (1992) 1.38
Attenuation correction of thallium SPECT using differential attenuation of thallium photons. J Nucl Med (1992) 1.38
Multiple paths of sugar-sensing and a sugar/oxygen overlap for genes of sucrose and ethanol metabolism. J Exp Bot (2000) 1.37
Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls. Ann Rheum Dis (2007) 1.36
Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations. Eur J Nucl Med (1998) 1.34
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. Cancer (1980) 1.34
Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin. Science (1980) 1.32
Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen. Cancer Res (1973) 1.31
The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels. J Nucl Med (1994) 1.30
Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinations. Cancer (1978) 1.29
Sheathlin: cloning, cDNA/polypeptide sequences, and immunolocalization of porcine enamel sheath proteins. J Dent Res (1997) 1.28
Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am (2000) 1.26
BDNF and learning: Evidence that instrumental training promotes learning within the spinal cord by up-regulating BDNF expression. Neuroscience (2007) 1.25
Cloning and characterization of porcine enamelin mRNAs. J Dent Res (1997) 1.25
The multivariate L1-median and associated data depth. Proc Natl Acad Sci U S A (2000) 1.25
Coupling energy metabolism with a mechanism to support brain-derived neurotrophic factor-mediated synaptic plasticity. Neuroscience (2006) 1.23
Role of opiate receptors in the regulation of colonic transit. Gastroenterology (1988) 1.21
Localization of GW-39 human tumors in hamsters by affinity-purified antibody to carcinoembryonic antigen. Cancer Res (1977) 1.21
Temporal lobe epilepsy due to hippocampal sclerosis in pediatric candidates for epilepsy surgery. Neurology (2001) 1.21
Choice, relative reinforcer duration, and the changeover ratio. J Exp Anal Behav (1982) 1.21
In vivo hybridisation of human tumour and normal hamster cells. Nature (1974) 1.20
Immunoscintigraphy of Pneumocystis carinii pneumonia in AIDS patients. J Nucl Med (1994) 1.19
Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen. Cancer Res (1980) 1.19
Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer. J Nucl Med (1998) 1.17
Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment. J Nucl Med (1994) 1.17
Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen. Cancer Res (1987) 1.16
Malignant potential of murine stromal cells after transplantation of human tumors into nude mice. Science (1981) 1.16
The select action of hippocampal calcium calmodulin protein kinase II in mediating exercise-enhanced cognitive function. Neuroscience (2006) 1.16
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma. Int J Cancer (1997) 1.15
Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody. Int J Cancer (1993) 1.15
Insulin-stimulated glucose transport in human adipocytes. Am J Physiol (1979) 1.14
Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res (1995) 1.14
Detection of carcinoembryonic antigen in tissue sections by immunoperoxidase. J Immunol Methods (1975) 1.14
Imaging approach in radioimmunodetection. Cancer Res (1980) 1.14
Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2. Cancer Immunol Immunother (1993) 1.10
Cloning, cDNA sequence, and alternative splicing of porcine amelogenin mRNAs. J Dent Res (1996) 1.10
Adult sexual revictimization among black women sexually abused in childhood: a prospective examination of serious consequences of abuse. Child Maltreat (2000) 1.09
Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells. Cancer (1994) 1.09
Improved prospects for cancer therapy with radiolabeled antibody fragments and peptides? J Nucl Med (1996) 1.09
Cloning human enamelin cDNA, chromosomal localization, and analysis of expression during tooth development. J Dent Res (2000) 1.09
Oncofetal and other tumor-associated antigens of the human digestive system. Curr Top Pathol (1976) 1.08
Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines. Immunology (1999) 1.08
Radiation dose estimates for oral agents used in upper gastrointestinal disease. J Nucl Med (1983) 1.07
Identification of a colon-specific antigen (CSA) in normal and neoplastic tissues. J Immunol (1975) 1.06
Human chorionic gonadotropin radioantibodies in the radioimmunodetection of cancer and for disclosure of occult metastases. Proc Natl Acad Sci U S A (1981) 1.06
Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies. Oncogene (2007) 1.06
Absolute organ activity estimated by five different methods of background correction. J Nucl Med (1998) 1.06
Cloning, characterization, and heterologous expression of exon-4-containing amelogenin mRNAs. J Dent Res (1997) 1.05
GW-39: a new human tumor serially transplantable in the golden hamster. Transplantation (1966) 1.04
Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies. Cancer Res (1983) 1.04
Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas. Biochem J (1996) 1.04
Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma. Blood (2001) 1.04